The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals

Journal of Obesity

Volumn 2013, Issue , 2013, Pages

  Tumova, Eva ^a   Sun, Wensheng ^b   Jones, Peter H ^b   Vrablik, Michal ^a   Ballantyne, Christie M ^b   Hoogeveen, Ron C ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD; CALORIC RESTRICTION; COMPARATIVE STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALORIC RESTRICTION; CHOLESTEROL, LDL; FEMALE; HUMANS; INFLAMMATION; INSULIN; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84893824733     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2013/729515     Document Type: Article

References (50)

1. York D. A., Rössner S., Caterson I., Chen C. M., James W. P., Kumanyika S., Martorell R., Vorster H. H., Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: group I: worldwide demographics of obesity. Circulation 2004 110 18 E463 E470 2-s2.0-14744276680
2. Flegal K. M., Carroll M. D., Ogden C. L., Johnson C. L., Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association 2002 288 14 1723 1727 2-s2.0-0037048669
3. Kelly T., Yang W., Chen C.-S., Reynolds K., He J., Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity 2008 32 9 1431 1437 2-s2.0-51849146897 10.1038/ijo.2008.102
4. Girman C. J., Rhodes T., Mercuri M., Pyörälä K., Kjekshus J., Pedersen T. R., Beere P. A., Gotto A. M., Clearfield M., The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). American Journal of Cardiology 2004 93 2 136 141 2-s2.0-0346962890 10.1016/j.amjcard.2003.09.028 (Pubitemid 38058719)
5. Hunt K. J., Resendez R. G., Williams K., Haffner S. M., Stern M. P., National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study. Circulation 2004 110 10 1251 1257 2-s2.0-4444329030 10.1161/01.CIR.0000140762.04598.F9 (Pubitemid 39202341)
6. Goodpaster B. H., Kelley D. E., Wing R. R., Meier A., Thaete F. L., Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999 48 4 839 847 2-s2.0-0033054725 (Pubitemid 29153085)
7. Kelley D. E., Goodpaster B., Wing R. R., Simoneau J.-A., Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. American Journal of Physiology: Endocrinology and Metabolism 1999 277 6 E1130 E1141 2-s2.0-0033400310 (Pubitemid 30046009)
8. Park Y.-W., Zhu S., Palaniappan L., Heshka S., Carnethon M. R., Heymsfield S. B., The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine 2003 163 4 427 436 2-s2.0-0037463608 10.1001/archinte.163.4.427 (Pubitemid 36241019)
9. Ford E. S., Giles W. H., Dietz W. H., Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. Journal of the American Medical Association 2002 287 3 356 359 2-s2.0-0037116641 (Pubitemid 34251969)
10. Galassi A., Reynolds K., He J., Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine 2006 119 10 812 819 2-s2.0-33748776056 10.1016/j.amjmed.2006.02.031 (Pubitemid 44415613)
11. Hopps E., Noto D., Caimi G., Averna M. R., A novel component of the metabolic syndrome: the oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases 2010 20 1 72 77 2-s2.0-72649106550 10.1016/j.numecd. 2009.06.002
12. Leopold J. A., Loscalzo J., Oxidative risk for atherothrombotic cardiovascular disease. Free Radical Biology and Medicine 2009 47 12 1673 1706 2-s2.0-70449520200 10.1016/j.freeradbiomed.2009.09.009
13. Van Guilder G. P., Hoetzer G. L., Greiner J. J., Stauffer B. L., DeSouza C. A., Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 2006 14 12 2127 2131 2-s2.0-33846308173 10.1038/oby.2006.248 (Pubitemid 46121966)
14. Esterbauer H., Gebicki J., Puhl H., Jurgens G., The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biology and Medicine 1992 13 4 341 390 2-s2.0-0026657363 10.1016/0891-5849(92) 90181-F
15. Steinbrecher U. P., Parthasarathy S., Leake D. S., Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proceedings of the National Academy of Sciences of the United States of America 1984 81 12 3883 3887 2-s2.0-0000061171 (Pubitemid 14087823)
16. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Jeong Ai Kim J. A. K., Bamshad B., Esterson M., Fogelman A. M., Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. Journal of Clinical Investigation 1990 85 4 1260 1266 2-s2.0-0025359852 (Pubitemid 20123772)
17. Shih P. T., Elices M. J., Fang Z. T., Ugarova T. P., Strahl D., Territo M. C., Frank J. S., Kovach N. L., Cabanas C., Berliner J. A., Vora D. K., Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating β 1 integrin. Journal of Clinical Investigation 1999 103 5 613 625 2-s2.0-0033104713 (Pubitemid 29122414)
18. Liao F., Berliner J. A., Mehrabian M., Navab M., Demer L. L., Lusis A. J., Fogelman A. M., Minimally modified low density lipoprotein is biologically active in vivo in mice. Journal of Clinical Investigation 1991 87 6 2253 2257 2-s2.0-0025946464
19. Kusuhara M., Chait A., Cader A., Berk B. C., Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1 141 148 2-s2.0-0031015765 (Pubitemid 27057336)
20. Yi Hui Huang Y. H. H., Ronnelid J., Frostegard J., Oxidized LDL induces enhanced antibody formation and MHC class II- dependent IFN- γ production in lymphocytes from healthy individuals. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 10 1577 1583 2-s2.0-0029157513
21. Holvoet P., Lee D.-H., Steffes M., Gross M., Jacobs D. R. Jr., Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. Journal of the American Medical Association 2008 299 19 2287 2293 2-s2.0-44249104442 10.1001/jama.299.19.2287 (Pubitemid 351724395)
22. Hoogeveen R. C., Ballantyne C. M., Bang H., Heiss G., Duncan B. B., Folsom A. R., Pankow J. S., Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia 2007 50 1 36 42 2-s2.0-33845955836 10.1007/s00125-006-0533-8 (Pubitemid 46035850)
23. Hulthe J., Bokemark L., Wikstrand J., Fagerberg B., The metabolic syndrome, LDL particle size, and atherosclerosis: the atherosclerosis and insulin resistance (AIR) study. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 9 2140 2147 2-s2.0-0033818023
24. Steinberg D., Antioxidants and atherosclerosis. A current assessment. Circulation 1991 84 3 1420 1425 2-s2.0-0026039122
25. Stremler K. E., Stafforini D. M., Prescott S. M., McIntyre T. M., Human plasma platelet-activating factor acetylhydrolase: oxidatively fragmented phospholipids as substrates. Journal of Biological Chemistry 1991 266 17 11095 11103 2-s2.0-0025908558 (Pubitemid 21906916)
26. Steinbrecher U. P., Pritchard P. H., Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. Journal of Lipid Research 1989 30 3 305 315 2-s2.0-0024521694 (Pubitemid 19082060)
27. 2 in oxidized human low density lipoprotein. Journal of Biological Chemistry 2008 283 10 6428 6437 2-s2.0-44449119583 10.1074/jbc.M709970200
28. 2 platelet activating factor-acetylhydrolase. Atherosclerosis Supplements 2002 3 4 57 68 2-s2.0-0038352228 10.1016/S1567-5688(02)00045-4 (Pubitemid 38234487)
29. 2 activity is a marker of small, dense LDL particles in human plasma. Clinical Chemistry 2005 51 12 2264 2273 2-s2.0-28044453286 10.1373/clinchem.2005.058404 (Pubitemid 41692569)
30. 2 Journal of Lipid Research 2007 48 2 348 357 2-s2.0-33846868176 10.1194/jlr.M600249-JLR200 (Pubitemid 46220601)
31. 2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 6 1411 1416 2-s2.0-34249713287 10.1161/ATVBAHA.107.142679 (Pubitemid 46823453)
32. 2 high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2004 109 7 837 842 2-s2.0-1342331006 10.1161/01.CIR.0000116763.91992.F1 (Pubitemid 38252734)
33. Klebanoff S. J., Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 2005 77 5 598 625 2-s2.0-18244390487 10.1189/jlb.1204697 (Pubitemid 40628741)
34. Carr A. C., McCall M. R., Frei B., Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 7 1716 1725 2-s2.0-0033927959
35. Hazell L. J., Stocker R., Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochemical Journal 1993 290 1 165 172 2-s2.0-0027516393 (Pubitemid 23081215)
36. Hazell L. J., Davies M. J., Stocker R., Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochemical Journal 1999 339 3 489 495 2-s2.0-0033136258 10.1042/0264-6021:3390489 (Pubitemid 29243509)
37. Upston J. M., Terentis A. C., Stocker R., Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. The FASEB Journal 1999 13 9 977 994 2-s2.0-0033006542 (Pubitemid 29249724)
38. Chesney J. A., Mahoney J. R. Jr., Eaton J. W., A spectrophotometric assay for chlorine-containing compounds. Analytical Biochemistry 1991 196 2 262 266 2-s2.0-0026200339 10.1016/0003-2697(91)90463-4
39. Savenkova M. I., Mueller D. M., Heinecke J. W., Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. Journal of Biological Chemistry 1994 269 32 20394 20400 2-s2.0-0028076845 (Pubitemid 24260440)
40. Shao B., Oda M. N., Oram J. F., Heinecke J. W., Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Current Opinion in Cardiology 2006 21 4 322 328 2-s2.0-33748157807 10.1097/01.hco.0000231402.87232.aa (Pubitemid 44315065)
41. Meuwese M. C., Stroes E. S. G., Hazen S. L., van Miert J. N., Kuivenhoven J. A., Schaub R. G., Wareham N. J., Luben R., Kastelein J. J. P., Khaw K.-T., Boekholdt S. M., Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. The EPIC-Norfolk prospective population study. Journal of the American College of Cardiology 2007 50 2 159 165 2-s2.0-34347225913 10.1016/j.jacc.2007.03.033 (Pubitemid 47002189)
42. Case C. C., Jones P. H., Nelson K., Smith E. O., Ballantyne C. M., Impact of weight loss on the metabolic syndrome. Diabetes, Obesity and Metabolism 2002 4 6 407 414 2-s2.0-0036847663 10.1046/j.1463-1326.2002.00236.x (Pubitemid 35345455)
43. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C. Jr., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005 112 17 2735 2752 2-s2.0-27444443876 10.1161/CIRCULATIONAHA.105.169404 (Pubitemid 41532612)
44. White I. R., Royston P., Wood A. M., Multiple imputation using chained equations: issues and guidance for practice. Statistics in Medicine 2011 30 4 377 399 2-s2.0-78651256743 10.1002/sim.4067
45. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
46. 2) activity in healthy obese women. Nutrition, Metabolism and Cardiovascular Diseases 2008 18 7 477 482 2-s2.0-47949099324 10.1016/j.numecd.2007.04.004
47. Hanusch-Enserer U., Zorn G., Wojta J., Kopp C. W., Prager R., Koenig W., Schillinger M., Roden M., Huber K., Non-conventional markers of atherosclerosis before and after gastric banding surgery. European Heart Journal 2009 30 12 1516 1524 2-s2.0-67651123155 10.1093/eurheartj/ehp108
48. Pierce G. L., Beske S. D., Lawson B. R., Southall K. L., Benay F. J., Donato A. J., Seals D. R., Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 2008 52 1 72 79 2-s2.0-46449084157 10.1161/HYPERTENSIONAHA.108. 111427
49. Shin M.-J., Hyun Y. J., Kim O. Y., Kim J. Y., Jang Y., Lee J. H., Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. International Journal of Obesity 2006 30 10 1529 1534 2-s2.0-33749126980 10.1038/sj.ijo.0803304 (Pubitemid 44470202)
50. Roberts C. K., Won D., Pruthi S., Kurtovic S., Sindhu R. K., Vaziri N. D., Barnard R. J., Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. Journal of Applied Physiology 2006 100 5 1657 1665 2-s2.0-33646429745 10.1152/japplphysiol.01292.2005